| Bioactivity | sPLA2 inhibitor 2 (compound 6a) is a sPLA2 inhibitor, with IC50 of 0.0475 μM. sPLA2 inhibitor 2 can be used in diabetes research[1]. |
| Formula | C20H18N6O4S2 |
| Molar Mass | 470.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Alasmary FAS, et al. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. J Enzyme Inhib Med Chem. 2024 Dec;39(1):2395985. |